Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MISSILE: Mycophenolate Mofetil for Atherosclerosis in SLE
NCT01101802Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Mar 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of mycophenolate mofetil in systemic lupus erythematosus (SLE) and atherosclerosis (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Flow mediated dilation at 8 weeks. Started Mar 2006; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
systemic lupus erythematosus (SLE)atherosclerosis
Beyond the preview
Go deeper on NCT01101802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101802.